Xiamen Amoytop Biotech Co. Ltd Financials

Market Capitalization CN¥29.73 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	33.83
Forward PE	26.04
Price to Sales TTM	CN¥10.10
Price to Book MRQ	CN¥10.71
Enterprise to Revenue	9.69
Enterprise to EBITDA	27.45

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	29.91%
Operating Margin	32.18%
Return on Assets TTM	21.82%
Return on Equity TTM	37.06%

Income Statement

Revenue TTM	CN¥2,945,201,152
Revenue per Share TTM	CN¥7.21
Quarterly Revenue Growth	23.50%
Gross Profit TTM	CN¥2,752,530,176
EBITDA	CN¥985,333,340
Net Income to Common TTM	CN¥880,923,584
Diluted EPS TTM	CN¥2.14
Quarterly Earnings Growth YoY	41.40%

Balance Sheet

Total Cash MRQ	CN¥818,112,832
Total Cash per Share MRQ	CN¥2.01
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.66
Current Ratio MRQ	5.56
Book Value per Share MRQ	CN¥6.76

Cash Flow

Operating Cash Flow TTM	CN¥558,709,504
Levered Free Cash Flow TTM	CN¥51,171,788

688278 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	406,800,000
Float Shares	126,099,864
Avg 10 Volume	1,896,425
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	65.99%
% Held by Institutions	14.28%

Stock Price Summary

Beta	-0.32
Fifty Two Week Low	CN¥46.30
Fifty Two Week High	CN¥88.38
Fifty Two Week Change	27.40%
Day 50 MA	CN¥73.61
Day 200 MA	CN¥75.46

Dividends and Splits

Forward Annual Dividend Rate	CN¥2.48
Forward Annual Dividend Yield	3.45%
Trailing Annual Dividend Rate	CN¥0.62
Trailing Annual Dividend Yield	0.86%
Payout Ratio	18.98%
Dividend Date
Ex Dividend Date	2025-05-09
Last Split Factor
Last Split Date